These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


90 related items for PubMed ID: 9987444

  • 21. Use of a liquid-based, thin-layer Pap test in a community hospital. Impact on cytology performance and productivity.
    Sass MA.
    Acta Cytol; 2004; 48(1):17-22. PubMed ID: 14969176
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Performance of a semiautomated Papanicolaou smear screening system: results of a population-based study conducted in Guanacaste, Costa Rica.
    Sherman ME, Schiffman M, Herrero R, Kelly D, Bratti C, Mango LJ, Alfaro M, Hutchinson ML, Mena F, Hildesheim A, Morales J, Greenberg MD, Balmaceda I, Lorincz AT.
    Cancer; 1998 Oct 25; 84(5):273-80. PubMed ID: 9801201
    [Abstract] [Full Text] [Related]

  • 26. ThinPrep Pap Test. Accuracy for glandular disease.
    Ashfaq R, Gibbons D, Vela C, Saboorian MH, Iliya F.
    Acta Cytol; 1999 Oct 25; 43(1):81-5. PubMed ID: 9987455
    [Abstract] [Full Text] [Related]

  • 27. Quality assurance in cervical smears: 100% rapid rescreening vs. 10% random rescreening.
    Amaral RG, Zeferino LC, Hardy E, Westin MC, Martinez EZ, Montemor EB.
    Acta Cytol; 2005 Oct 25; 49(3):244-8. PubMed ID: 15966284
    [Abstract] [Full Text] [Related]

  • 28. Effect of cellularity on the sensitivity of detecting squamous lesions in liquid-based cervical cytology.
    Studeman KD, Ioffe OB, Puszkiewicz J, Sauvegeot J, Henry MR.
    Acta Cytol; 2003 Oct 25; 47(4):605-10. PubMed ID: 12920754
    [Abstract] [Full Text] [Related]

  • 29. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
    Renshaw AA, Deschênes M, Auger M.
    Am J Clin Pathol; 2009 Jun 25; 131(6):776-81. PubMed ID: 19461082
    [Abstract] [Full Text] [Related]

  • 30. Enhancing the performance of the AutoPap 300 QC system with optimal staining and presentation of cervical smears.
    Colgan TJ, Smith J, Patten SF, Lee JS.
    Acta Cytol; 1997 Jun 25; 41(1):50-5. PubMed ID: 9022726
    [Abstract] [Full Text] [Related]

  • 31. [Automation of cytological analysis of cervical smears].
    Cenci M, Giovagnoli MR, Olla SV, Drusco A, Vecchione A.
    Minerva Ginecol; 1999 Jun 25; 51(7-8):291-8. PubMed ID: 10536424
    [Abstract] [Full Text] [Related]

  • 32. [Analysis of the intralaboratory diagnostic variability in the Imola cervical screening program].
    Fabbris E, Bucchi L, Folicaldi S, Amadori A, Ghidoni D, Medri M, Bondi A.
    Pathologica; 1998 Apr 25; 90(2):127-32. PubMed ID: 9619055
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Atypical squamous cells of undetermined significance. Current laboratory practices of participants in the College of American Pathologists Interlaboratory. Comparison Program in Cervicovaginal Cytology.
    Davey DD, Nielsen ML, Naryshkin S, Robb JA, Cohen T, Kline TS.
    Arch Pathol Lab Med; 1996 May 25; 120(5):440-4. PubMed ID: 8639046
    [Abstract] [Full Text] [Related]

  • 36. Computer-assisted rescreening of clinically important false negative cervical smears using the PAPNET Testing System.
    Rosenthal DL, Acosta D, Peters RK.
    Acta Cytol; 1996 May 25; 40(1):120-6. PubMed ID: 8604564
    [Abstract] [Full Text] [Related]

  • 37. Percentages of cervical cytologic diagnoses as a quality assurance method.
    Mulligan NJ, de las Morenas A, Soto-Wright V, O'Brien MJ.
    Acta Cytol; 1998 May 25; 42(4):928-32. PubMed ID: 9684579
    [Abstract] [Full Text] [Related]

  • 38. Quality assurance in gynecologic cytology. The value of cytotechnologist-cytopathologist discrepancy logs.
    Cibas ES, Dean B, Maffeo N, Allred EN.
    Am J Clin Pathol; 2001 Apr 25; 115(4):512-6. PubMed ID: 11293898
    [Abstract] [Full Text] [Related]

  • 39. The human false-negative rate of rescreening Pap tests. Measured in a two-arm prospective clinical trial.
    Renshaw AA, Lezon KM, Wilbur DC.
    Cancer; 2001 Apr 25; 93(2):106-10. PubMed ID: 11309775
    [Abstract] [Full Text] [Related]

  • 40. The primary screening clinical trials of the TriPath AutoPap System.
    Wilbur DC, Norton MK.
    Epidemiology; 2002 May 25; 13 Suppl 3():S30-3. PubMed ID: 12071481
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.